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General experimental protocol 
 
Reactions were carried out in oven-dried glassware under an inert Ar atmosphere using double 
vacuum manifold with the inert gas passing through a bed of silica gel and molecular sieves.  
 
NMR spectra were acquired on either Bruker Avance 400 (1H at 400 MHz, 13C at 100 MHz, 
19F at 376 MHz) equipped with BBFO probe, Bruker Avance III HD 500 (1H at 500 MHz, 13C 
at 125 MHz) equipped with BBFO probe, Bruker Avance III 500 (1H at 500 MHz, 13C at 125 
MHz) equipped with TCI cryoprobe or Bruker Avance III 700 (13C at 176 MHz) equipped with 
a TCI cryoprobe. The chemical shifts (d) are reported in parts per million (ppm) and are quoted 
relative to centre of the residual non-deuterated solvent peak for  δH (CDCl3: 7.26 ppm; MeCN: 
1.94 ppm; D2O: 4.79 ppm) and δC (CDCl3: 77.16 ppm; MeCN: 1.32 ppm and 118.26 ppm). 
Chemical shifts δF are quoted relative to CFCl3 (δF CFCl3: 0.00 ppm). 13C NMR spectra were 
recorded using the DEPT Q or UDEFT pulse sequence with broadband 1H decoupling. 19F{1H} 
spectra were recorded with inverse-gating, to avoid errors on the integrals. Coupling constants 
(J) are given in Hertz (Hz). Signal splitting patterns are described as: br s (broad singlet), d 
(doublet), s (singlet), sept (septet), t (triplet). Spectroscopic data were assigned based on the 
combination of one- and two-dimensional experiments (HSQC and HMBC). 
 
Melting points were determined in Pyrex capillaries on an Electrothermal 9100 melting point 
apparatus without correction.  
 
High and low resolution mass spectra were recorded at the EPSRC National Mass 
Spectrometry Service, Swansea or at the University of St Andrews by Caroline Horsburgh on 
a Waters Micromass LCT time of flight mass spectrometer coupled to a Waters 2975 HPLC 
system. Values are reported as a ratio of mass to charge (m/z). 
 
IR spectra were recorded using the ATR technique on Shimadzu IR Affinity-1S FTIR 
spectrometer. 
 
Flash Column chromatography was carried out on Merck Geduran silica gel 60 (240-400 
mesh), eluting with solvents as supplied, under a positive pressure of compressed air.  
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Analytical thin layer chromatography (TLC) was carried out on Merck silica gel 60 F254 
aluminium-supported thin layer chromatography sheets. Visualisation was by absorption of 
UV light (lmax 254 or 365 nm), or thermal development after dipping in basic aqueous solution 
of potassium permanganate (KMnO4) or butanolic solution of ninhydrin and acetic acid.  
 
HPLC analyses were performed using either a Waters 600E Multisolvent HPLC system or 
Shimadzu Prominence with reverse phase column as indicated in individual experiment. 
 
Single crystal X-ray Diffraction analyses were carried out by Dr David B. Cordes and Prof 
Alexandra M. Z. Slawin at the University of St Andrews. All diffraction data except for (14) 
were collected by using a Rigaku FR-X Ultrahigh brilliance Microfocus RA generator/confocal 
optics and Rigaku XtaLAB P200 system, with Mo Kα radiation                (λ = 0.71075 Å). Data 
for (14) were collected at 125 K by using a Rigaku MM-007HF High brilliance RA 
generator/confocal optics and Rigaku XtaLAB P200 system, with Cu Kα radiation (λ = 1.54187 
Å). Intensity data for all samples were collected using ω steps accumulating area detector 
images spanning at least a hemisphere of reciprocal space. All data were corrected for Lorentz 
polarisation effects. A multiscan absorption correction was applied by using CrystalClear1 or 
CrysAlisPro.2 Structures were solved by Patterson (PATTY3) or direct (SIR2004,4 SIR20115) 
methods and refined by full-matrix least-squares against F2 (SHELXL-20136). Non-hydrogen 
atoms were refined anisotropically, and hydrogen atoms were refined using a riding model. All 
calculations were performed using the CrystalStructure7 interface. 
 
Anhydrous solvents (THF, DCM) were obtained from the MBraun MB SPS-800 solvent 
purification system, by passage through two drying columns and dispensed under an argon 
atmosphere. Anhydrous MeOH and MeCN were distilled from calcium hydride in recycling 
still.8 Anhydrous dioxane was available commercially.  
 
Chemicals Muscimol 1 analytical grade was purchased from Sigma Aldrich. Methyl-3-
hydroxyisoxazole-5-carboxylate 6 was purchased from Fluorochem UK and used without 
further purification. n-BuLi was purchased from Sigma Aldrich (as a 2.5 M solution in 
hexanes) and titrated against diphenylacetic acid before use. Other chemicals not specifically 
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mentioned were purchased from Acros UK, Sigma Aldrich, Fluorochem UK or Alfa Aesar UK 
and were used without further purification.  
Experimental  Section  
Methyl 3-isopropoxyisoxazole-5-carboxylate (7)9 
 
 
 
Isopropyl bromide (3.9 mL, 42.0 mmol, 1.5 eq) was added to a mixture of methyl 3-
hydroxyisoxazole-5-carboxylate (6) (4.0 g, 28.0 mmol, 1.0 eq) and K2CO3 (4.3 g, 31.0 mmol, 
1.1 eq) in DMF (50 mL). The mixture was stirred for 1 h at 60 °C then at 55 °C overnight. 
After cooling down to rt, water (80 mL) was added and the aqueous phase was extracted into 
Et2O (3 x 50 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting yellow residue was purified by silica gel 
column chromatography (petroleum ether/Et2O, 90:10) to afford methyl 3-
isopropoxyisoxazole-5-carboxylate (7) (4.0 g, 77%) as colourless oil: Rf 0.61 (petroleum 
ether/Et2O, 80:20, UV/KMnO4); dH (500 MHz, CDCl3) 6.48 (1H, s, H-4), 4.93 (1H, sept, 3JHH 
6.1, H-8), 3.92 (3H, s, H-7), 1.38 (6H, d, 3JHH 6.1, H-9); dC (125 MHz, CDCl3) 170.9 (C-3), 
160.0 (C-5), 157.3 (C-6), 101.5 (C-4), 74.2 (C-8), 52.9 (C-7), 21.9 (C-9); HRMS m/z (NSI+), 
found: [M+H]+ 186.0758, C8H12NO4 requires [M+H]+ 186.0761.The data were in good 
agreement with the literature values.9  
 
 
5-Hydroxymethyl-3-isopropoxyisoxazole (8) 
 
 
 
NaBH4 (1.53 g, 40.5 mmol, 2.5 eq) was added to a solution of methyl                                              3-
isopropoxyisoxazole-5-carboxylate (7) (3.00 g, 16.2 mmol, 1.0 eq) in MeOH (80 mL) at     0 
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°C. The mixture was stirred at rt overnight and quenched with a saturated solution NH4Cl (50 
mL). The reaction mixture was partitioned between water (60 mL) and EtOAc (60 mL). The 
aqueous layer was extracted into EtOAc (3 x 80 mL). The combined organic layers were 
washed with brine (50 mL), dried over MgSO4, filtered and concentrated under reduced 
pressure to afford a pale yellowish oil, which was purified by silica gel column                            
chromatography (petroleum ether/EtOAc, 80:20) to afford 5-hydroxymethyl-3-
isopropoxyisoxazole (8) (2.29 g, 90%) as colourless  oil: Rf 0.79 (petroleum ether/EtOAc, 
70:30, KMnO4); FT-IR (ATR, cm-1) 3367 (OH), 2982, 1622, 1504, 1456, 1386, 1375, 1338, 
1111; dH (500 MHz, CDCl3) 5.83 (1H, s, H-4), 4.85 (1H, sept, 3JHH 6.1, H-7), 4.63 (2H, s,     H-
6), 2.61 (br s, 1H, -OH), 1.36 (6H, d, 3JHH 6.1, H-8); dC (125 MHz, CDCl3) 171.9 (C-5), 171.2 
(C-3), 94.1 (C-4), 73.5 (C-7), 56.9 (C-6), 22.0 (C-8); HRMS m/z (NSI+), found: [M+H]+ 
158.0809, C7H12NO3 requires [M+H]+ 158.0812.  
 
 
5-Bromomethyl-3-isopropoxyisoxazole (9) 
 
	  
 
CBr4 (7.26 g, 21.9 mmol, 2.2 eq) and PPh3 (7.82 g, 29.8 mmol, 3.0 eq) were added to a solution 
of 5-hydroxymethyl-3-isopropoxyisoxazole (8) (1.56 g, 9.94 mmol, 1.0 eq) in DCM (100 mL) 
at 0 °C. The reaction mixture was stirred at rt for 12 h and concentrated under reduced pressure. 
The resulting residue was purified by silica gel column chromatography (petroleum ether/Et2O, 
95:5) to afford 5-bromomethyl-3-isopropoxyisoxazole (9)                 (1.27 g, 58%) as a colourless 
oil: Rf 0.66 (petroleum ether/Et2O, 80:20 UV/KMnO4);            FT-IR (ATR, cm-1) 2980, 1618, 
1504, 1447, 1387, 1373, 1340, 1287, 1109, 1030, 916, 667; dH (500 MHz, CDCl3) 5.90 (1H, s, 
H-4), 4.89 (1H, sept, 3JHH 6.1, H-7), 4.33 (2H, s, H-6), 1.38 (6H, d, 3JHH 6.1,  H-8);  dC (125 
MHz, CDCl3) 171.0 (C-3), 167.8 (C-5), 95.9 (C-4), 73.6 (C-7), 22.0 (C-8), 19.2 (C-6); HRMS 
m/z (ESI+), found: [M+H]+ 219.9969,  C7H11NO279Br requires [M+H]+ 219.9968. 
 
5-Azidomethyl-3-isopropoxyisoxazole (10) 
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NaN3 (1.6 g, 25.0 mmol, 5.0 eq) was added to a solution of 5-bromomethyl-3-
isopropoxyisoxazole (9) (1.1 g, 5.0 mmol, 1.0 eq) in DMF (50 mL). After stirring at  80 °C for 
3.5 h, the resulting solution was diluted with water (60 mL) and the product was extracted into 
Et2O (5 x 60 mL). The combined organic layers were washed with a saturated solution of 
Na2CO3 (60 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The 
resulting yellowish oil was purified by silica gel column chromatography (petroleum 
ether/Et2O, 95:5) to give 5-azidomethyl-3-isopropoxyisoxazole (10) (828 mg, 91%)               as 
a colourless oil: Rf 0.64 (petroleum ether/Et2O, 80:20, KMnO4); FT-IR (ATR, cm-1) 2980, 
2100 (N3), 1622, 1506, 1456, 1446, 1339, 1111, 1029; dH (500 MHz, CDCl3) 5.87 (1H, s,     H-
4), 4.89 (1H, sept, 3JHH 6.1, H-7), 4.31 (2H, s, H-6), 1.38 (6H, d, 3JHH 6.1, H-8);                dC 
(CDCl3, 125 MHz) 171.1 (C-3), 166.9 (C-5), 95.5 (C-4), 73.7 (C-7), 45.9 (C-6), 22.0       (C-
8); HRMS m/z (NSI+), found: [M+H]+ 183.0876, C7H11N4O2 requires [M+H]+ 183.0877. 
 
 
5-Aminomethyl-3-isopropoxyisoxazole (11) 
 
 
 
PMe3 (1.0 M solution in THF, 13.2 mL, 13.2 mmol, 3.0 eq) was added to a solution of             5-
azidomethyl-3-isopropoxyisoxazole (10) (800 mg, 4.40 mmol, 1.0 eq) in THF (30 mL) at     0 
°C. The resulting mixture was stirred at 0 °C for 1 h and was quenched by slow addition of 
water (50 mL). The organic phase was separated and the aqueous phase was extracted into 
EtOAc (3 x 80 mL). The combined organic layers were washed with brine, dried over MgSO4, 
filtered and concentrated under reduced pressure. The resulting residue was purified by silica 
gel column chromatography (EtOAc, 100) affording 5-aminomethyl-3-isopropoxyisoxazole 
(11) (446 mg, 65%) as yellowish oil: Rf 0.40 (EtOAc/MeOH, 80:20, ninhydrin); FT-IR (ATR, 
cm-1) 3383, 3315 (NH2), 2980, 1616, 1499, 1449, 1385, 1373, 1340, 1111, 1028; dH (500 MHz, 
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CDCl3)  5.70 (1H, t, 4JHH 0.7, H-4), 4.85 (1H, sept, 3JHH 6.1, H-7), 3.82 (2H, s, H-6), 1.56 (br 
s, 2H, -NH2), 1.35 (6H, d, 3JHH 6.1, H-8); dC (125 MHz, CDCl3) 174.3 (C-5), 171.2 (C-3), 92.6 
(C-4), 73.2 (C-7), 38.8 (C-6), 22.0 (C-8); HRMS m/z (NSI+), found: [M+H]+ 157.0967, 
C7H13N2O2 requires [M+H]+ 157.0972 
 
5-(tert-Butyloxycarbonyl)aminomethyl-3-isopropoxyisoxazole (12)10  
 
 
 
Na2CO3 (543 mg, 5.12 mmol, 2.0 eq) was added to a solution of 5-aminomethyl-3-
isopropoxyisoxazole (11) (400 mg, 2.56 mmol, 1.0 eq) in dioxane/water (3:1 v/v mixture,       8 
mL) at 0 °C, followed by dropwise addition of di-tert-butyl dicarbonate (0.65 mL, 2.82 mmol, 
1.1 eq) in dioxane (2 mL). After stirring at rt overnight, dioxane was removed under reduced 
pressure and the residue was diluted with Et2O (30 mL) and washed with water      (50 mL). 
The aqueous layer was extracted into Et2O (3 x 30 mL). The combined organic layers were 
combined, dried over MgSO4, filtered and concentrated under reduced pressure. The resulting 
yellow residue was purified by silica gel column chromatography (petroleum ether/Et2O, 
70:30) to afford 5-(tert-butyloxycarbonyl)aminomethyl-3-isopropoxyisoxazole (12) (590 mg, 
90%) as a colourless viscous oil that crystallised in time: Rf 0.74 (petroleum ether/Et2O, 50:50, 
ninhydrin); mp 49-50 °C; FT-IR (ATR, cm-1) 3306 (NH), 2980, 1712 (C=O), 1616, 1522 
(NH), 1497, 1449, 1384, 1366, 1271, 1254, 1138, 1036, 901;                   dH (500 MHz, CDCl3) 
5.74 (1H, s, H-4), 5.00 (br s, 1H, -NH), 4.85 (1H, sept, 3JHH 6.1, H-7),                4.29 (2H, d, 
3JHH 5.9, H-6), 1.44 (9H, s, H-11), 1.36 (6H, d, 3JHH 6.1,  H-8);  dC (125 MHz, CDCl3) 171.2 
(C-3), 170.2 (C-5), 155.6 (C-9), 94.0 (C-4), 80.4 (C-10), 73.4 (C-7), 37.1        (C-6), 28.4 (C-
11), 22.0 (C-8); HRMS m/z (NSI+), found: [M+H]+ 257.1496, C12H21N2O4 requires [M+H]+ 
257.1496. 
 
5-(tert-Butyloxycarbonyl)aminomethyl-4-fluoro-3-isopropoxyisoxazole (13) 
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n-BuLi (1.7 mL, 2.5 M in hexanes, 4.29 mmol, 2.2 eq) was added dropwise  to a solution of 5-
(tert-butyloxycarbonyl)aminomethyl-3-isopropoxyisoxazole (12) (500 mg, 1.95 mmol,    1.0 
eq) at -78 °C. The mixture was stirred for 1.5 h at -78 °C and added a solution of NFSI (676 
mg, 2.15 mmol, 1.1 eq) in THF (2 mL). The mixture was stirred for 2 h at -78 °C and the 
temperature was allowed to warm to rt over 12 h. The reaction mixture was quenched with 
aqueous NH4Cl (10 mL) and the organic phase was extracted into EtOAc (3 x 20 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. The resulting residue was purified by silica gel column chromatography (petroleum 
ether/Et2O, 80:20) to afford 5-(tert-butyloxycarbonyl)aminomethyl-4-fluoro-3-
isopropoxyisoxazole (13) (160 mg, 30%) as a colourless viscous oil that crystallised in time: 
Rf 0.67 (petroleum ether/Et2O, 50:50, ninhydrin); mp 63-65 °C; FT-IR (ATR, cm-1) 3333 
(NH), 2983, 1680 (C=O), 1612, 1526 (NH), 1285, 1269, 1252, 1107, 1078, 916, 907;           dH 
(400 MHz, CDCl3) 4.97 (br s, 1H, -NH, overlapped with H-7), 4.92 (1H, sept, 3JHH 6.1, H-7), 
4.36 (2H, d, 3JHH 5.0, H-6), 1.44 (9H, s, H-11),  1.40 (6H, d, 3JHH 6.1, H-8); dC (125 MHz, 
CDCl3) 161.5 (d, 2JCF 12.5, C-3), 155.5 (C-9), 152.3 (d, 2JCF 19.2, C-5), 134.3 (d, 1JCF 254.6, 
C-4), 80.5 (C-10), 74.6 (C-7), 35.0 (C-6), 28.4 (C-11), 22.0 (C-8); dF (376 MHz, CDCl3)                             
-188.0 (1F, s, CF); HRMS m/z (NSI+), found: [M+H]+ 275.1404, C12H20N2O4F requires 
[M+H]+ 275.1402. 
 
 
5-Ammoniomethyl-4-fluoro-3-isopropoxyisoxazole trifluoroacetate (14) 
 
 
 
 
TFA (1.7 mL, 22.0 mmol, 40.0 eq) was added to a solution of 5-(tert-
butyloxycarbonyl)aminomethyl-4-fluoro-3-isopropoxyisoxazole (13) (150 mg, 0.55 mmol, 1.0 
eq) in DCM (8 mL). After stirring at rt overnight, the solvent was removed under reduced 
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pressure and the resulting residue was purified by silica gel column chromatography 
(DCM/MeOH, 95:5) to afford 5-ammoniomethyl-4-fluoro-3-isopropoxyisoxazole 
trifluoroacetate salt (14) (155 mg, 98%) as light yellow solid: Rf 0.54 (DCM/MeOH, 90:10, 
ninhydrin); mp 116-118 °C; FT-IR (ATR, cm-1) 2988, 2926, 2843, 2612, 1670 (C=O), 1541, 
1516, 1508, 1435, 1381, 1352, 1339, 1290, 1242, 1120, 1177, 1138, 1103, 1064, 986;                                                  
dH (400 MHz, CD3CN) 6.76 (br s, 3H, -NH3), 4.91 (1H, sept, 3JHH 6.1, H-7), 4.15 (2H, s,      H-
6), 1.38 (6H, d, 3JHH 6.1, H-8); dC (100 MHz, CD3CN) 162.5 (q, 2JCF 30.5, TFA), 162.3   (d, 
2JCF 12.5, C-3), 150.8 (d, 2JCF 20.4, C-5), 136.3 (d, 1JCF 255.7, C-4), 117.6 (q, 1JCF 291.9, TFA), 
76.0 (C-7), 34.0 (C-6), 21.9 (C-8); dF (376 MHz, CD3CN) -76.4 (3F, s, TFA),                     -
186.5 (1F, s, CF); HRMS m/z (ESI+), found: [M-TFA+H]+ 175.0876, C7H12N2O2F requires                                    
[M-TFA+H]+175.0877.  
 
 
5-Aminomethyl-4-fluoro-3-hydroxyisoxazole (3) 
 
	  
 
A solution of HBr 33% in AcOH (0.79 mL, 4.5 mmol, 25 eq) was added to                             5-
aminomethyl-4-fluoro-3-isopropoxyisoxazole trifluoroacetate (14) (53 mg, 0.18 mmol, 1.0 eq) 
and stirred at 60 °C for 17 h. The solvent was removed under vacuum and the residue was 
washed with water (3 x 2 mL). The residue was passed through a reverse phase C18 cartridge 
(Varian Mega Bond Elut C18, preconditioned with water) and the product was eluted with 
water (3 x 10 mL). The fractions were combined and concentrated under reduced pressure. The 
product was further purified by preparative HPLC (Waters system, using a Phenomenex 
Kingsorb C18 (250 x 21.2 mm, 5 µ) column equipped with security guard cartridge), with an 
isocratic mobile phase of H2O at flow rate of 8.0 mL/min detected at 254 nm. Fractions 
containing product (tR = 7.80 min) were collected and concentrated under reduced pressure. 
Fluoromuscimol (3) was obtained as a colourless solid after freeze drying (11 mg, 36%). 
Analytical HPLC analysis was performed using Shimadzu system (Phenomenex Kingsorb C18 
(150 x 4.6 mm, 5 µ) column), with an isocratic mobile phase of H2O at flow rate of 0.8 mL/min 
detected at 254 nm (tR = 1.97 min, purity >99%);                                                       mp >200 
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°C (dec.); FT-IR (ATR, cm-1) 3429, 2982, 2621 (br), 2237, 2099 (br), 1521, 1458, 1273, 1219, 
1144, 1088, 1069, 988; dH (400 MHz, D2O) 4.21 (2H, d, 4JHF 1.5, H-6); 1H{19F} (400 MHz, 
D2O) 4.21 (2H, s, H-6); dC (176 MHz, D2O) 167.8 (d, 2JCF 11.0, C-3), 145.6  (d, 2JCF 21.8, C-
5), 139.1    (d, 1JCF 257.1, C-4), 32.5 (d, 3JCF 3.1, C-6); dF (376 MHz, D2O)                               -
185.2 (1F, s, CF); HRMS m/z (ESI+), found: [M+H]+ 133.0407, C4H6N2O2F requires 
[M+H]+133.0413. 
 
 
5-Azidomethyl-4-iodo-3-isopropoxyisoxazole (15) 
 
 
 
NIS (202 mg, 0.90 mmol, 1.5 eq) was added to a solution of 5-azidomethyl-3-
isopropoxyisoxazole (10) (110 mg, 0.60 mmol, 1.0 eq) in TFA (5 mL) at rt. After stirring at rt 
overnight, the solvent was removed under reduced pressure and the residue was purified by 
silica gel column chromatography (petroleum ether/Et2O, 95:5), affording 5-azidomethyl-4-
iodo-3-isopropoxyisoxazole (15) (159 mg, 86%) as yellowish oil: Rf 0.87 (petroleum 
ether/Et2O, 90:10, UV/KMnO4); FT-IR (ATR, cm-1) 2980, 2095 (N3), 1607, 1506, 1427, 1387, 
1373, 1333, 1287, 1182, 1109, 1087, 914, 839, 768, 700; dH (500 MHz, CDCl3) 4.95 (1H, sept, 
3JHH 6.2, H-7), 4.37 (2H, s, H-6), 1.42 (6H, d, 3JHH 6.2, H-8); dC (125 MHz, CDCl3) 170.3 (C-
3), 167.4 (C-5), 74.9  (C-7), 53.2 (C-4), 45.3 (C-6), 21.9 (C-8); HRMS m/z (NSI+), found: 
[M+H]+ 308.9846, C7H10N4O2127I requires [M+H]+ 308.9843. 
 
5-Aminomethyl-4-iodo-3-isopropoxyisoxazole (16) 
 
 
 
PMe3 (1.0 M solution in THF, 1.47 mL, 1.47 mmol, 3.0 eq) was added to a solution of          5-
azidomethyl-4-iodo-3-isopropoxyisoxazole (15) (150 mg, 0.49 mmol, 1.0 eq) in THF              (8 
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mL) at 0 °C. The resulting mixture was stirred at 0 °C for 1 h and was quenched by slow 
addition of water (10 mL). The organic phase was separated and the aqueous phase was 
extracted into EtOAc (3 x 20 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated under reduced pressure and the residue was purified by 
silica gel column chromatography (EtOAc, 100), affording                                        5-
aminomethyl-4-iodo-3-isopropoxyisoxazole (16) (114 mg, 83%) as yellowish oil: Rf 0.50 
(EtOAc/MeOH, 90:10, UV/ninhydrin);  FT-IR (ATR, cm-1) 3397, 3377 (NH2), 2978, 1593, 
1502, 1431, 1385, 1373, 1335, 1107, 1084, 916, 837, 754, 721, 691; dH (500 MHz ,CDCl3) 
4.91 (1H, sept, 3JHH 6.2, H-7), 3.85 (2H, s, H-6), 1.53 (br s, 2H, -NH2), 1.39 (6H, d, 3JHH 6.2, 
H-8); dC (125 MHz, CDCl3) 173.2 (C-5), 170.2 (C-3), 74.4 (C-7), 49.2 (C-4), 38.5                      (C-
6), 21.9 (C-8); HRMS m/z (NSI+), found: [M+H]+ 282.9935, C7H12N2O2127I requires [M+H]+ 
282.9938. 
 
5-(tert-Butyloxycarbonyl)aminomethyl-4-iodo-3-isopropoxyisoxazole (17) 
 
 
 
Na2CO3 (541 mg, 5.10 mmol, 2.0 eq) was added to a solution of                                                     5-
aminomethyl-4-iodo-3-isopropoxyisoxazole (16) (720 mg, 2.55 mmol, 1.0 eq) in 
dioxane/water (3:1 v/v mixture, 16 mL) at 0 °C, followed by dropwise addition of di-tert-butyl 
dicarbonate (0.65 mL, 2.81 mmol, 1.1 eq) in dioxane (2 mL). After stirring at rt overnight, 
dioxane was removed under reduced pressure and the residue was diluted with Et2O (40 mL) 
and washed with water (50 mL). The aqueous layer was extracted into Et2O        (3 x 40 mL). 
The combined organic layers were combined, dried over MgSO4, filtered and concentrated 
under reduced pressure. The resulting yellow residue was purified by silica gel column 
chromatography (petroleum ether/Et2O, 70:30) to afford 5-(tert-
butyloxycarbonyl)aminomethyl-4-iodo-3-isopropoxyisoxazole (17) (788 mg, 81%) as a 
colourless viscous oil: Rf 0.53 (petroleum ether/Et2O, 60:40, UV/ninhydrin); FT-IR (ATR, cm-
1) 3352 (NH), 2980, 1699 (C=O), 1603, 1506 (NH), 1433, 1387, 1368, 1337, 1281, 1250, 1167, 
1090, 916; dH (500 MHz, CDCl3) 4.98 (br s, 1H, -NH), 4.90 (1H, sept, 3JHH 6.2, H-7), 4.37 
(2H, d, 3JHH 5.9, H-6), 1.44 (9H, s, H-11), 1.39 (6H, d, 3JHH 6.2, H-8);                            dC (125 
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MHz, CDCl3) 170.3 (C-3), 169.3 (C-5), 155.4 (C-9), 80.4 (C-10), 74.5 (C-7), 50.5 (C-4), 37.1 
(C-6), 28.5 (C-11), 21.9 (C-8); HRMS m/z (ESI+), found: [M+Na]+ 405.0273, 
C12H19N2O4127INa requires [M+Na]+ 405.0282. 
 
 
5-Di(tert-butyloxycarbonyl)aminomethyl-4-iodo-3-isopropoxyisoxazole (18) 
 
 
 
 
DMAP (34.2 mg, 0.28 mmol, 0.2 eq) and di-tert-butyl dicarbonate (0.65 mL, 2.82 mmol, 2.0 
eq) were added to a solution of 5-(tert-butyloxycarbonyl)aminomethyl-4-iodo-3-
isopropoxyisoxazole (17) (540 mg, 1.41 mmol, 1.0 eq) in MeCN (25 mL). The reaction mixture 
was heated under reflux for 3 h and allowed to cool to rt. The reaction was diluted with DCM 
(20 mL), and washed with water  (30 mL). The aqueous layer was extracted into DCM (3 x 30 
mL). The combined organic layers were combined, dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting brown oil was purified by silica gel                                  
column chromatography (petroleum ether/Et2O, 90:10) to afford 5-di(tert-
butyloxycarbonyl)aminomethyl-4-iodo-3-isopropoxyisoxazole (18) (592  mg, 87%) as a 
colourless viscous oil: Rf 0.68 (petroleum ether/Et2O, 70:30, UV/ninhydrin);  FT-IR (ATR, 
cm-1) 2986, 1730 (C=O), 1688 (C=O), 1601, 1510, 1435, 1416, 1383, 1368, 1337, 1227, 1165, 
1140, 1121, 1090, 918, 858, 849, 791, 760; dH (500 MHz, CDCl3) 4.90 (1H, sept, 3JHH 6.2, H-
7), 4.83 (2H, s, H-6), 1.48 (18H, s, H-11), 1.39 (6H, d, 3JHH 6.2, H-8); dC (125 MHz, CDCl3) 
171.0 (C-3), 169.7 (C-9), 151.7 (C-5), 83.5 (C-10), 74.4 (C-7), 48.8 (C-4), 42.7       (C-6), 28.2 
(C-11), 21.9 (C-8); HRMS m/z (ESI+), found: [M+Na]+ 505.0796, C17H27N2O6127INa requires 
[M+Na]+ 505.0806. 
 
 
5-Di(tert-butyloxycarbonyl)aminomethyl-4-trifluoromethyl-3- isopropoxyisoxazole (19) 
 
13 
 
 
 
Methyl 2,2-difluoro-2-(fluorosulfonyl) acetate (MFDSA) (945 mg, 4.92 mmol, 4.0 eq) was 
added to a preformed solution of 5-di(tert-butyloxycarbonyl)aminomethyl-4-iodo-3-
isopropoxyisoxazole (18) (592 mg, 1.23 mmol, 1.0 eq), copper(I) iodide (47.6 mg, 0.25 mmol, 
0.2 eq) and HMPA (1 ml) in DMF (8 ml).  The reaction mixture was heated under reflux at 80 
°C for 24 h. The clear, dark orange reaction mixture was cooled to room temperature and 
diluted with Et2O (10 ml), washed with a saturated aqueous solution of NH4Cl (15 ml) and 
brine (15 ml). The aqueous layer was back-extracted into                                   Et2O (3 x 20 
ml) and the combined organic layers were combined,                                                 dried over 
MgSO4, filtered and concentrated under reduced pressure. The resulting yellowish oil was 
purified by silica gel column chromatography (petroleum ether/Et2O, 90:10)               to    afford 
5-di(tert-butyloxycarbonyl)aminomethyl-4-trifluoromethyl-3-isopropoxyisoxazole (19) (177 
mg, 34%) as a colourless viscous oil: Rf 0.66 (petroleum ether/Et2O, 80:20, ninhydrin); FT-IR 
(ATR, cm-1) 2982, 1761 (C=O), 1699 (C=O), 1647, 1516, 1472, 1718, 1369, 1333, 1308, 1260, 
1227, 1130, 1109, 1078, 1036, 918, 854, 843.764; dH (400 MHz, CDCl3) 4.97 (2H, q, 5JHF 1.0, 
H-6), 4.91 (1H, sept, 3JHH 6.2, H-7), 1.49 (18H, s, H-11), 1.40 (6H, d, 3JHH 6.2, H-8); 1H{19F} 
(400 MHz, CDCl3) 4.97 (2H, s, H-6), 4.91 (1H, sept, 3JHH 6.2, H-7), 1.49 (18H, s, H-11), 1.40 
(6H, d, 3JHH 6.2, H-8);  dC (176 MHz, CDCl3) 169.4 (C-9), 167.4 (C-3), 151.6 (C-5), 121.2 (q, 
1JCF 254.6, CF3), 99.2 (q, 2JCF 39.4, C-4), 83.8 (C-10),  74.9 (C-7), 42.2 (C-6), 28.1 (C-11), 
21.8 (C-8); dF (376 MHz, CDCl3) -57.7 (3F, t, 5JHF 1.0, CF3); 19F{1H} (376 MHz, CDCl3) -57.7 
(s, CF3);.HRMS m/z (ESI+), found: [M+Na]+ 447.1704, C18H27N2O6F3Na requires [M+Na]+ 
447.1713. 
 
 
5-Aminomethyl-4-trifluoromethyl-3-hydroxyisoxazole (4) 
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TFA (0.17 mL, 2.2 mmol, 20.0 eq) was added to a solution of 5-di(tert-
butyloxycarbonyl)aminomethyl-4-trifluoromethyl-3-isopropoxyisoxazole (19) (45 mg, 0.11 
mmol, 1.0 eq) in DCM (5 mL). After stirring at rt for 6 h, the solvent was removed under 
reduced pressure to afford a hygroscopic colourless crystalline solid contained (20) (35 mg), 
which was used in the subsequent step without further purification. A solution of HBr 33% in 
AcOH (0.9 mL, 5.0 mmol, 50 eq) was added to crude (20) (35 mg, 0.10 mmol, 1.0 eq) and 
stirred at 60 °C for 48 h. The solvent was removed under vacuum and the residue was washed 
with water (3 x 2 mL). The residue was passed through a reverse phase C18 cartridge (Varian 
Mega Bond Elut C18, preconditioned with water) and the product was eluted with water       (3 
x 10 mL). The fractions were combined and concentrated under reduced pressure. The product 
was further purified by preparative HPLC (Waters system, using a Phenomenex Kingsorb C18 
(250 x 21.2 mm, 5 µ) column equipped with security guard cartridge) with an isocratic mobile 
phase of H2O at flow rate of  8.0 mL/min detected at 254 nm. Fractions containing product (tR 
= 9.10 min) were collected and concentrated under reduced pressure. Trifluoromethylmuscimol 
(4) was obtained as a colourless solid after freeze drying (7.2 mg, 36% over 2 steps). Analytical 
HPLC analysis was performed using Shimadzu system (Phenomenex Kingsorb C18    (150 x 
4.6 mm, 5 µ) column), with an isocratic mobile phase of H2O at flow rate of  0.8 mL/min 
detected at 254 nm (tR = 2.27 min, purity >98%); mp 165-168 °C (dec); FT-IR (ATR, cm-1) 
2997, 2891, 2631 (br), 1667, 1491, 1425, 1371,              1344, 1161, 1109, 1042, 978, 745; dH 
(400 MHz, D2O) 4.38 (s, H-6); dC (176 MHz, D2O) 172.2 (C-3), 163.7 (C-5), 121.6 (q, 1JCF 
267.8, CF3), 103.2 (q, 2JCF 39.5, C-4), 34.5 (C-6);     dF (376 MHz, D2O) -58.9 (s, CF3); HRMS 
m/z (ESI+), found: [M+H]+ 183.0373, C5H6N2O2F3 requires  [M+H]+ 183.0381. 
 
 
 
 
5-Aminomethyl-4-iodo-3-hydroxyisoxazole (5) 
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A solution of HBr 33% in AcOH (1.7 mL, 9.5 mmol, 25 eq) was added to                              5-
aminomethyl-4-iodo-3-isopropoxyisoxazole (16) (107 mg, 0.38 mmol, 1.0 eq) and stirred at 60 
°C for 17 h. The solvent was removed under vacuum and the residue was washed with water 
(3 x 2 mL). The residue was passed through a reverse phase C18 cartridge (Varian Mega Bond 
Elut C18, preconditioned with water) and the product was eluted with water        (3 x 10 mL). 
The fractions were combined and concentrated under reduced pressure. The product was 
further purified by preparative HPLC (Waters system, using a Phenomenex Kingsorb C18 (250 
x 21.2 mm, 5 µ) column equipped with security guard cartridge), with an isocratic mobile phase 
of H2O at flow rate of 8.0 mL/min detected at 254 nm. Fractions containing product (tR = 8.97 
min) were collected and concentrated under reduced pressure.  Iodomuscimol (5) was obtained 
as a colourless solid after freeze drying (17.3 mg, 19%). Analytical HPLC analysis was 
performed using Shimadzu system (Phenomenex Kingsorb C18 (150 x 4.6 mm, 5 µ) column), 
with an isocratic mobile phase of H2O at flow rate of                             0.8 mL/min detected at 
254 nm (tR = 2.19 min, purity >99%); mp 161-162 °C;                        FT-IR (ATR, cm-1) 3350, 
2990, 2637 (br), 2363, 1616, 1487, 1358, 1254, 1077, 1037, 968; dH (400 MHz, D2O) 4.21 (s, 
2H, H-6); dC (176 MHz, D2O) 176.4 (C-3), 163.2 (C-5), 61.6   (C-4), 35.3 (C-6); HRMS m/z 
(ESI+), found: [M+H]+ 240.9466, C4H6N2O2127I requires  [M+H]+ 240.9474. 
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5-Di(tert-butyloxycarbonyl)aminomethyl-4-trifluoromethyl-3-isopropoxyisoxazole (19) 
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5-Aminomethyl-4-trifluoromethyl-3-hydroxyisoxazole (4) 
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5-Aminomethyl-4-iodo-3-hydroxyisoxazole (5) 
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Analytical HPLC of 5-aminomethyl-4-fluoro-3-hydroxyisoxazole (3) 
 
 
 
 
Analytical HPLC of 5-aminomethyl-4-trifluoromethyl-3-hydroxyisoxazole (4) 
 
 
 
 
 
Analytical HPLC of 5-aminomethyl-4-iodo-3-hydroxyisoxazole (5) 
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Computational	  Details	  for	  the	  conformational	  analysis	  of	  1	  and	  3	  
Conformational analyses of muscimol and its fluoro derivative were performed (employing the 
Gaussian09 suite of programs)11 at the B3LYP12/6-311+G** level of density functional theory, 
using an implicit solvent model, namely the polarizable conductor variant of the polarizable 
continuum model (CPCM),13 with the default settings in Gaussian 09.  
Assuming zwitterionic structures throughout, initial relaxed scans of the rotational profiles for 
the ammonium side group (using the C-C-C-NH3 dihedral as coordinate in steps of 10º, see 
Figure S1) revealed the existence of only one minimum each for muscimol and fluoromuscimol 
(or rather, enantiomeric pairs of minima) with an out-of-plane orientation of the ammonium 
side group. After full optimisation the C-C-C-NH3 dihedral angles were 113.9 º and 106.7º for 
muscimol and fluoromuscimol, respectively (the latter value in fair agreement with the 
structure in the solid, where this angle is 120.8 º). Two transition states each were located, 
where this ammonium group passes either the O atom from the heterocycle or the F/H 
substituent (fully optimised in Cs symmetry and characterised by the presence of single 
imaginary frequencies). The resulting energy barriers are collected in Table S1. 
 
a)  b)  
Figure S1: Relaxed scans of muscimole (1, left) and fluoromascimole (3, right) at the 
B3LYP/6-311+G**/CPCM(H2O) level using the C-C-C-NH3 dihedral angle as scan coordinate 
(in degrees); energies given in atomic units (see text and Table S1 for fully optimised values). 
 
Table S1: Energy barriers (DE‡, kJ mol-1) relative to the respective minimum, B3LYP/6-
311+G**/CPCM(H2O) level. 
 
             transition state 
X 
TS1  
TS2  
X = H  1 8.7 8.8 
X = F  3 10.6 13.2 
 
Coordinates of the DFT-optimised structures 
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Cartesian coordinates in Å, B3LYP/6-311+G** optimised (xyz format) 
 
14 
 muscimol 1 minimum 
 H  5.5915505642 1.4762840606 4.5905737316 
 O  3.4415453294 0.8926122252 2.1961969565 
 O  6.8841890636 1.2158073377 2.0279188197 
 N  4.669558058 0.9115626414 1.4404813864 
 N  1.6835841968 2.3219503264 4.1362873194 
 H  1.3372287762 2.288319156 3.1741345623 
 H  0.8720190045 2.3352536855 4.7587910332 
 H  2.1823379243 3.2072522973 4.2551517672 
 C  5.6580315391 1.1396241463 2.3346440189 
 C  5.0655654957 1.2812596792 3.6697155352 
 C  3.7403613413 1.1172250097 3.4940504793 
 C  2.5873192326 1.1392952651 4.4320088318 
 H  2.9213913709 1.239622063 5.4614351954 
 H  1.9648646934 0.2499081266 4.3352853331 
 
 14 
 fluoromuscimol 3 minimum 
 F  5.6731525095 1.6386612459 4.763524858 
 O  3.4710381457 0.7881704137 2.1742273284 
 O  6.9116307994 1.2513437833 2.0777613999 
 N  4.718025713 0.8183765467 1.4454044061 
 N  1.6971281701 2.3448051183 4.1764436787 
 H  1.3369118056 2.3714257524 3.2192148226 
 H  0.8919391713 2.3497265327 4.80753171 
 H  2.2200028985 3.210040816 4.3344024464 
 C  5.6818799197 1.1337457805 2.3341111611 
 C  5.0317521443 1.3119034794 3.6288665897 
 C  3.7140015633 1.0903228431 3.4712438011 
 C  2.5651464691 1.1175199876 4.4051362591 
 H  2.9047551473 1.1571182282 5.4374134193 
 H  1.9142955434 0.2545994723 4.2695381197 
 
 14 
 fluoromuscimol 3 TS1      
 C  -0.0007103118 0. -0.0468448822 
 C  -0.0755759354 0. 1.4112808795 
 C  1.177659792 0. 1.8922162321 
 C  1.7447526642 0. 3.2756137343 
 O  -0.967485039 0. -0.8569120705 
 N  1.3056083067 0. -0.3862286216 
 F  -1.223419747 0. 2.1171497966 
 N  3.2468319193 0. 3.2213570699 
 H  1.443509216 0.8850731144 3.8356852436 
 H  1.443509216 -0.8850731144 3.8356852436 
 H  3.6412699264 0. 4.1648235276 
 H  3.6076826095 -0.8235159619 2.7322246547 
 H  3.6076826095 0.8235159619 2.7322246547 
 O  2.0486587691 0. 0.8590725009 
 
 14 
 fluoromuscimol 3 TS2      
 C  0.0092884634 0. -0.1377261004 
 C  -0.0842555962 0. 1.3195205877 
 C  1.1627557521 0. 1.8208435349 
 C  1.7501984651 0. 3.1927902959 
 O  -0.9486918938 0. -0.9585143506 
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 N  1.318861783 0. -0.4538703908 
 F  -1.2439322083 0. 2.015836441 
 N  0.6820400919 0. 4.2507333565 
 H  2.3653595894 -0.884910198 3.3579203392 
 H  2.3653595894 0.884910198 3.3579203392 
 H  1.108473892 0. 5.1808114402 
 H  0.080767727 0.8264047657 4.1931712498 
 H  0.080767727 -0.8264047657 4.1931712498 
 O  2.0467150874 0. 0.8034486344 
 
 14 
 muscimol 1 TS1      
 C  0.0145026071 0. -0.033540476 
 C  -0.1033754135 0. 1.4292967073 
 C  1.1609589512 0. 1.8880770335 
 C  1.7388005897 0. 3.2713377105 
 O  -0.9295994434 0. -0.8771721742 
 N  1.324352449 0. -0.3728937648 
 H  -1.0187514162 0. 1.9988847445 
 N  3.2423231631 0. 3.2117828712 
 H  1.4418368723 0.8853384793 3.8325253889 
 H  1.4418368723 -0.8853384793 3.8325253889 
 H  3.6437261039 0. 4.1520061115 
 H  3.5976246574 -0.8221717606 2.7172547163 
 H  3.5976246574 0.8221717606 2.7172547163 
 O  2.0529013568 0. 0.8766148802 
 
 14 
 muscimol 1 TS2      
 C  0.0177947465 0. -0.1176283838 
 C  -0.1144751452 0. 1.3461519882 
 C  1.1482720261 0. 1.8162843311 
 C  1.7508066046 0. 3.1841777456 
 O  -0.9213252504 0. -0.9670479347 
 N  1.3284313924 0. -0.4401145902 
 H  -1.0460151907 0. 1.8895550531 
 N  0.6848627022 0. 4.241051218 
 H  2.3660859893 -0.8851127187 3.3485767692 
 H  2.3660859893 0.8851127187 3.3485767692 
 H  1.1007661998 0. 5.1753329942 
 H  0.0849689772 0.8266954327 4.1757382533 
 H  0.0849689772 -0.8266954327 4.1757382533 
 O  2.0472684624 0. 0.816270051 
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